1Pochis WT, Litzow JT, King BG,et al. Electrophysiologic findings in Fabry's disease with a short PR interval. Am J Cardiol,1994,74 (2) :203-204.
2Linhart A, Palecek T, Bultas J, et al. New insights in cardias structural changes in patients with Fabry's disease. Am Heart J,2000,139(6) : 1101 - 1108.
3Desnick RJ, Ioannou YA, Eng CM.a-galactosidase a deficiency:fabry disease. In : Scriver CH, Beaudet AL, Sly Ws, Valle D (eds).the metabolic and molecular bases of inherited disease. New York,McGraw HilI,V1 ,3733-3774.
4MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease :clinical manifestations an impact of disease in a cohort of 98 hemizygote males. J Med Genet, 2001,38 ; 750- 760.
5Tanaka H, Adachi K, Yamashlta Y,et al. Four cases of Fabry's disease mimicking hypertropic cardiomyopathy. J Cardiol, 1998,18 ;705-718.
6Goldman ME, Cantor R, Schwartz MF, et al. Echocardiographic abnormalities and disease severity in Fabry' Discase. J Am Coil Cordial,1986,7 :1157-1161.
7Mac Dermot KD, Holes A, Miners AH. Anderson-Fabry' Disease:clinica manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet, 2001,38 : 769- 807.
8Linhart A, Palecek T, Bultas J. Endiothelin-1 is associated with advanced clinical symptoms and-organ involvement in patients with Fahry' Disease. Eur Heart J ,2000,21 -492.
9Sewell AC,Bohles HJ,Perrot A,et al. Fsbry disease as a potential cause of hypertropic cardiomyopathy in adult man. J Inherit Metab Dis ,2001,24:135.
10Frustaci A, Chimenti C, Ricci R, et al. Improvement in cardiac function in the cardiac variant of Fabry' disease with galactose-infusion therapy. N Engl Med, 2001,3451 : 25-32.
